RxSight, Inc. (RXST) Return on equity 2021–2025
RxSight, Inc. (RXST) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-14.1%FY2025 · since FY2021: -35.2% → -14.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -14.1% | -4.4 pp |
| FY2024 | -9.8% | +20.5 pp |
| FY2023 | -30.3% | +43.9 pp |
| FY2022 | -74.3% | -39.0 pp |
| FY2021 | -35.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More RXST financial trends
RXST RevenueRXST Net incomeRXST Net marginRXST Gross profitRXST Gross marginRXST Operating incomeRXST Operating marginRXST Operating cash flowRXST Free cash flowRXST Capital expendituresRXST Stock buybacksRXST Dividends paidRXST Total assetsRXST Total liabilitiesRXST Shareholders’ equityRXST overview →